magnifying glass
logo for Reistone Biopharma

Reistone Biopharma

Get Full Access

Description

Reistone Biopharma Co. Ltd. is a leading biopharmaceutical company focused on developing novel medicines aimed at treating autoimmune and inflammatory diseases ... Read More

Headquarters

Headquarters:

1 Lincoln St, Fl 29 29-126, Boston, Massachusetts, 02111, United States
Employees

Employees:

140
Revenue

Revenue:

$26 Million
SIC Code 28,283
NAICS Code 32541,325
Popular Searches:

Reistone Biopharma Company Limited

Reistone Biopharma

Reistone Biopharma Co.

cn.reistonebio.com

Reistone Biopharma Company Ltd

Reistone Biopharma's Org Chart

Min Irwin
Min Irwin

Co-Founder & Chief Executive Office...

PhonePhoneEmailEmail
Susan Wu
Susan Wu

Executive Director, Corporate Strat...

PhonePhoneEmailEmail
Aik Goh
Aik Goh

Chief Medical Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Reistone Biopharma Company Metrics

Company Insights
Employee Growth Rate
Revenue
QuarterRevenue

'20 - Q3

3653000

'20 - Q4

3653000

'21 - Q1

11835000

'21 - Q2

11835000

Reistone Biopharma's Tech Stack

Microsoft Exchange Online

By

Microsoft

Office 365

By

Microsoft

nginx

By

NGINX

Baidu Ibsuyn API

By

Baidu
See more technologies

Reistone Biopharma News & Media

Reistone Announces Positive Results from a Phase II Study Evaluating SHR0302 Ointment for Patients with Mild-to-Moderate Atopic Dermatitis

SHANGHAI, Oct. 11, 2021 /PRNewswire/ -- Reistone Biopharma ("Reistone"), a leading biotech focused on development of treatments for immune and inflammation related diseases, today announced positive results from a Phase II study evaluating the safety and efficacy of twice daily SHR0302...

Reistone Announces Positive Topline Phase 2 Results for SHR0302, a Selective JAK1 Inhibitor, for Treatment of Patients with Alopecia Areata

- Once-daily, oral SHR0302, a selective JAK1 inhibitor, met primary efficacy endpoint and demonstrated statistically significant, and clinically relevant percentage change in SALT score versus placebo - A promising new late-stage asset with potential to fulfill the strong unmet medical...

Reistone Announces First Patient Dosed in Phase III Global Study in Atopic Dermatitis

SHANGHAI, May 13, 2021 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced the first patient has been dosed in their Phase III, global...
Subscribe to "Reistone Biopharma" News

Frequently Asked Questions regarding Reistone Biopharma

Where are Reistone Biopharma’s headquarters?

Reistone Biopharma’s headquarters are in 1 Lincoln St, Fl 29 29-126, Boston, Massachusetts, 02111, United States

What is Reistone Biopharma’s official website?

Reistone Biopharma’s official website is www.reistonebio.com

What is Reistone Biopharma’s Revenue?

Reistone Biopharma’s revenue is $26 Million

What is Reistone Biopharma’s SIC code?

Reistone Biopharma’s SIC: 28,283

What is Reistone Biopharma’s NAICS code?

Reistone Biopharma’s NAICS: 32541,325

How many employees are working in Reistone Biopharma?

Reistone Biopharma has 140 employees

What is Reistone Biopharma’s industry?

Reistone Biopharma is in the industry of: Biotechnology, Pharmaceuticals, Healthcare

What is Reistone Biopharma's tech stack?

The technologies that are used by Reistone Biopharma are: Microsoft Exchange Online, Office 365, nginx, Baidu Ibsuyn API

Who is Reistone Biopharma's CEO?

Reistone Biopharma's CEO is Min Irwin

See more information about Reistone Biopharma

Browse ZoomInfo’s Directories